Kozue Takahashi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Study protocol for a phase II clinical trial evaluating the safety and efficacy of favipiravir injection combined with oseltamivir in influenza treatment.

Study protocol for a phase II clinical trial evaluating the safety and efficacy of favipiravir injection combined with oseltamivir in influenza treatment.

Journal: BMJ open

Published: August 26, 2026

Clinical course and virologic dynamics of Mpox during tecovirimat treatment: Prospective multicenter case series in Japan.

Clinical course and virologic dynamics of Mpox during tecovirimat treatment: Prospective multicenter case series in Japan.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: May 19, 2026

Fluid management and outcomes of dengue fever in Japan: single-center descriptive study in a non-endemic country.

Fluid management and outcomes of dengue fever in Japan: single-center descriptive study in a non-endemic country.

Journal: Tropical medicine and health

Published: April 10, 2026

LC16m8 for Pre-exposure Prophylaxis Against Mpox in a High-Risk Population: An Open-Label Randomized Trial.

LC16m8 for Pre-exposure Prophylaxis Against Mpox in a High-Risk Population: An Open-Label Randomized Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: November 25, 2024

Efficacy and viral dynamics of tecovirimat in patients with MPOX: A multicenter open-label, double-arm trial in Japan.

Efficacy and viral dynamics of tecovirimat in patients with MPOX: A multicenter open-label, double-arm trial in Japan.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: September 01, 2023

Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved.

Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved.

Journal: Heliyon

Published: February 26, 2023

Factors associated with development and persistence of post-COVID conditions: A cross-sectional study.

Factors associated with development and persistence of post-COVID conditions: A cross-sectional study.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: March 09, 2022

Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan.

Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: July 08, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026